Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Craneware Share News (CRW)
CRW Share
Price
CRW Share
News
CRW Share
Chat
CRW Share
Trades846
CRW
Live RNS
CRW Share
Charts
CRW Level 2
Console
CRW Live
Share Price
CRW Broker
Ratings
CRW Directors
Deals
CRW Financial
Diary
CRW
Fundamentals
CRW Short
Positions1
CRW
Media
CRW Company
Research
CRW Company
Timeline1
Share Price Information for Craneware (CRW)
Last checked at -
Last checked at 
Intraday Craneware Share Chart
Craneware News
WINNERS & LOSERS: RC365 jumps on partnership; Craneware slides
(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Friday.
LONDON BROKER RATINGS: Shore raises Close Bros, cuts Capricorn Energy
(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and on Thursday:
LONDON MARKET OPEN: FTSE 100 edges higher as mining stocks rise
(Alliance News) - Stock prices in London opened slightly higher on Friday, in the wake of Thursday's US jobs report, with financial markets shut in th...
Craneware says revenue below market expectations on deferred contracts
(Alliance News) - Craneware PLC on Friday said it expects to report revenue and adjusted earnings below market expectations for the financial year tha...
LONDON BRIEFING: Craneware to miss full-year market expectations
(Alliance News) - Craneware expects to underperform market expectations, Caledonia Investments completes its investment in a garden centre operator wh...
Craneware results to miss forecasts on revenue delays
(Sharecast News) - AIM-listed Craneware has said it expects its full-year results to be below market expectations due to the timing of the 340B drug p...
Craneware results to miss forecasts on revenue delays
(Sharecast News) - AIM-listed Craneware has said it expects its full-year results to be below market expectations due to the timing of the 340B drug p...
Follow the stocks
